Fundraising Fox
/Companies
Sign in

Mana Bio

San Francisco, US · 21 employees on LinkedIn · 5 known investors

Find your way into Mana Bio

Sign up to see every warm intro you have to Mana Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mana Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Mana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines. The company aims to unlock RNA-based treatments for genetic diseases with unmet medical needs.

AI & Machine LearningBiotech

Founders & leadership

YDYogev Debbi
Yogev DebbiCo-Founder & CEO
RNRoy Nevo
Roy NevoCo-Founder & COORoy Nevo is Co-Founder and CTO of Mana.bio, a biotech company developing machine learning and nanotechnology approaches for nucleic acid therapeutics. He previously led engineering teams at monday.com and Twist Bioscience, bringing over 14 years of experience in interdisciplinary team management and product development.

Investors · 5

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: gaingels.com · Not right? Tell us

LionBirdlisted by LionBirdTel Aviv · $200K – $500K

How we know: LionBird's portfolio page · funding news · nfx.com · Not right? Tell us

NFXlisted by NFXSan Francisco · $250K – $5M

How we know: funding news · nfx.com · Not right? Tell us

Also in the syndicate · 1

Base4 Capital

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Mana Bio went on to found or lead other companies.

Omri DroryBoard MemberFounded Renewal BioKira RadinskyScientific Co-FounderFounded Diagnostic RoboticsThaminda RamanayakeBoard MemberFounded Anaveon

Related companies · 4

Nabla BioNabla is a drug development company that applies design discipline and scientific rigor to the development of new medicines. The company focuses on making drug development more systematic and iterative, serving the pharmaceutical and biotech industry.
OmniAbOmniAb develops transgenic animal platforms engineered to generate human antibodies for therapeutic drug discovery, serving biopharmaceutical researchers and drug developers.
Nosis BioNosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
ManifoldManifold Bio combines AI-guided protein design with high-throughput in vivo screening to engineer tissue-targeted biologics and deliver therapeutic payloads to specific organs. The company develops a computational and experimental platform to optimize pharmacokinetics and biodistribution directly in living systems for drug discovery and development.

Companies working in the same space as Mana Bio.

Frequently asked questions

What does Mana Bio do?
Mana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines. The company aims to unlock RNA-based treatments for genetic diseases with unmet medical needs.
Who founded Mana Bio?
Mana Bio was founded by Yogev Debbi, Roy Nevo.
Who are Mana Bio's investors?
Mana Bio's investors include Andreessen Horowitz, Gaingels, LionBird, NFX.
Where is Mana Bio headquartered?
Mana Bio is headquartered in San Francisco, US.